Medprin Medical

Medprin Medical (stock code: 301033) was founded in 2008 and is a technology innovation company focused on high-performance medical devices. Today, it has developed into one of the medical device companies in the global high-end market.

With patients' life and health as our foundation and clinical needs as our guide, we focus on innovative R&D and industrial translation, and have taken the lead globally in realizing the industrialization of biological additive manufacturing technology in the field of soft tissue repair, establishing Medprin Medical's technological position. Over the years, through sustained efforts in innovation, we have gradually formed four major technology platforms based on advanced manufacturing technology and centered on the medical application of synthetic materials. We have independently developed industrial equipment for implantable medical devices, breaking foreign technology monopolies and successfully achieving industrial translation. Meanwhile, we keep innovating technology and products in more frontier fields, gradually improving our overall solutions from neurosurgery to multiple departments.

We integrate rigorous quality management concepts throughout the entire product life cycle, building a scientific and effective quality management system. Benchmarking against global medical industry standards, we endow China's smart manufacturing with new connotations through top-tier technology, excellent products, and continuously optimized services.

Global layout is a consistent development strategy of Medprin Medical. The company is headquartered in Guangzhou, with a subsidiary in Germany, and its sales and service network covers more than 100 countries and regions, benefiting nearly 1.7 million patients. In long-term joint creation with partners, we uphold the values of caring, innovation, cooperation, and professionalism, converging global industrial resources to promote the healthy development of the innovative medical device ecosystem.